Free Trial
NASDAQ:NEOG

Neogen Q1 2026 Earnings Report

Neogen logo
$5.50 -0.24 (-4.18%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$5.52 +0.02 (+0.36%)
As of 09/12/2025 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neogen EPS Results

Actual EPS
N/A
Consensus EPS
$0.05
Beat/Miss
N/A
One Year Ago EPS
N/A

Neogen Revenue Results

Actual Revenue
N/A
Expected Revenue
$203.93 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Neogen Announcement Details

Quarter
Q1 2026
Time
Before Market Opens
Conference Call Date
Thursday, October 9, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

Neogen Earnings Headlines

Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.tc pixel
See More Neogen Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Neogen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Neogen and other key companies, straight to your email.

About Neogen

Neogen (NASDAQ:NEOG) is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E. coli, as well as methods for mycotoxin and allergen detection. These offerings are complemented by software, instrumentation and training services that help customers maintain regulatory compliance and optimize their quality control processes. The company regularly invests in research and development to expand its testing capabilities and to address emerging contaminants in the food supply chain.

Beyond food testing, Neogen serves the animal safety market with an array of products for livestock and companion animals. Its animal safety segment provides medicated and non‐medicated feed additives, premixes, disinfectants and veterinary instruments. These products support animal health and productivity in industries such as dairy, poultry, swine and aquaculture. Neogen also supplies nutritional feed supplements and environmental hygiene solutions that help producers manage disease risk and improve overall herd performance.

Neogen operates through a network of subsidiaries and distribution partners in more than 100 countries across North America, Europe, Asia and Latin America. The company is led by James Herbert, who serves as president and chief executive officer, and emphasizes a commitment to innovation, quality and customer support. By combining proprietary technologies with global reach, Neogen aims to address critical safety challenges in the food and animal health markets.

View Neogen Profile

More Earnings Resources from MarketBeat